Press Releases InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 12:28:59 2025-01-24 pm EST			5-day change	1st Jan Change
0.1700 ^CAD	-8.11%		-5.56%	-19.05%

Dec. 31	Innocan Pharma Closes Private Placement for $635,444	MT
Dec. 30	InnoCan Pharma Corporation announced that it has received CAD 0.635445 million in funding	CI

Press Releases

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025	Jan. 09	AQ
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60	Dec. 31	AQ
Innocan Pharma Announces Private Placement of Units	Dec. 19	AQ
Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024	Dec. 12	AQ
Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs	Nov. 26	AQ
InnoCan Pharma : MD&A Report for Three & Nine month period ended September 30, 2024	Nov. 21	PU
InnoCan Pharma : Financial Statements as of September 30, 2024	Nov. 21	PU
Innocan Pharma Reports Third Quarter 2024 Financial Results	Nov. 20	AQ
Innocan Pharma to Present at the 2024 ThinkEquity Conference	24-10-21	AQ
Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience	24-10-16	AQ
Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs	24-10-11	AQ
Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide	24-10-09	AQ
Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting	24-09-03	AQ
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options	24-08-29	AQ
Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration	24-08-22	AQ
Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million	24-08-12	AQ
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center	24-07-29	AQ
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center	24-07-26	AQ
Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA Meeting	24-07-02	AQ
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs	24-06-11	AQ
Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million	24-05-27	AQ
FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain	24-05-21	AQ
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey	24-05-09	AQ
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain	24-04-22	AQ
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M	24-04-01	AQ

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Pharmaceuticals

Press Releases

Filters